Eventide Asset Management - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 270 filers reported holding IMMUNOGEN INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2023$22,622,950
+9.7%
763,000
-41.3%
0.37%
-0.5%
Q3 2023$20,631,000
-15.9%
1,300,0000.0%0.37%
-10.6%
Q2 2023$24,531,000
+415.4%
1,300,000
+30.0%
0.42%
+453.3%
Q1 2022$4,760,000
-35.8%
1,000,0000.0%0.08%
-21.1%
Q4 2021$7,420,0001,000,0000.10%
Other shareholders
IMMUNOGEN INC shareholders Q2 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders